Logo of Al-Modawat Specialized Medical Co.
Qualified investors will continue subscription to 475,000 shares of Al-Modawat Specialized Medical Co. in its initial public offering (IPO) on the Nomu-Parallel Market, until the close of trading tomorrow, Feb. 5.
The offered shares represent 20% of the company's SAR 23.75 million post-IPO capital, divided into 2.38 million shares, at a price range of SAR 93-111.
Al-Modawat posted SAR 10.9 million net profit for H1 2023, a rise of 200% year-on-year, backed by collective growth in sales of operating segments, mainly medical services.
|
Interim Income Statement (SAR mln) |
|||
|
Period |
H1 2022 |
H1 2023 |
Change |
|
Sales |
25.3 |
37.2 |
+47% |
|
Gross Profit |
11.9 |
21.4 |
+80% |
|
Gross Profit Margins (%) |
47.0% |
57.5% |
+10.5% |
|
Net Profit |
3.6 |
10.9 |
+200% |
|
Number of Shares (mln) |
1.9 |
1.9 |
-- |
|
EPS |
1.92 |
5.75 |
+200% |
The company's market capitalization, based on the subscription price range, will range between SAR 220-263 million, with the earnings per share (EPS) at 12.55-14.97x, as per profits for the last 12 months.
|
Annual Income Statement (SAR mln) |
|||
|
Period |
2021 |
2022 |
Change |
|
Sales |
40.9 |
58.5 |
+43% |
|
Gross Profit |
14.7 |
28.5 |
+94% |
|
Gross Profit Margins (%) |
35.9% |
48.7% |
+12.8% |
|
Net Profit |
(2.2) |
10.3 |
-- |
|
Number of Shares (mln) |
1.9 |
1.9 |
-- |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}